Home » Posts tagged with » NanoDimension
Icosavax, a new vaccine development company, launched in Seattle

Icosavax, a new vaccine development company, launched in Seattle

Icosavax, a new pharma company, focused on developing vaccines against infectious diseases, has been launched in Seattle, Washington. The vaccine development company is backed by $51 million capital raised through a Series A financing round led by Qiming Venture Partners USA. Other investors in Icosavax are Sanofi Ventures, Adams Street Partners, and NanoDimension, alongside continuing […]

Amphivena Therapeutics raises $62m to advance AMV564 into solid tumors

Amphivena Therapeutics funding round : Amphivena Therapeutics has raised $62 million in a Series C financing round to expand the clinical development of its lead candidate AMV564 into solid tumors and also to develop its T cell engagement portfolio. Based in California, Amphivena Therapeutics is a clinical-stage immuno-oncology company focused on developing T cell engager […]

Continue reading …